K. Landmark et al., USE OF FISH OILS APPEARS TO REDUCE INFARCT SIZE AS ESTIMATED FROM PEAK CREATINE-KINASE AND LACTATE-DEHYDROGENASE ACTIVITIES, Cardiology, 89(2), 1998, pp. 94-102
In 753 patients with acute myocardial infarction, use of fish oils (FO
, n = 242) before onset of infarction seemed to reduce infarct size as
estimated from peak creatine kinase (CKmax) and lactate dehydrogenase
(LDmax) activities. The study had an observational exposed/nonexposed
design, and both crude and adjusted effects were looked for. Crude Ef
fects: In the restricted cohort of patients not receiving thrombolytic
treatment (n = 411), FO reduced CKmax from 879 to 759 U/l (2 p = 0.03
0) and LDmax from 870 to 768 U/l (2 p = 0.011), respectively. More of
these patients in the lowest enzyme quartiles used FO, p for linear tr
end was for CKmax 0.008 and for LDmax 0.06, respectively. Adjusted Eff
ects: In patients not receiving thrombolytic treatment, FO reduced CKm
ax (2 p = 0.007) and LDmax (2 p = 0.005), but in patients receiving su
ch treatment, CKmax and LDmax values increased, 2 p being 0.036 and 0.
097, respectively. In patients not receiving thrombolysis, FO increase
d the incidence of small infarcts (the 25% quartile), odds ratio for C
Kmax was 1.82 (2 p = 0.018) and for LDmax 1.66 (2 p = 0.048), respecti
vely. The results indicate that FO may reduce infarct size and the inc
idence of large infarcts. In addition, FO seems to enhance the effect
of thrombolysis.